Cannabis was recognized as an essential business in several markets when the shutdown came into effect, including Canada and some US states,
Tilray Inc. (TLRY) Q2 2020 Earnings Call Transcript
Tilray Inc. (NASDAQ: TLRY) Q2 2020 earnings call dated Aug. 10, 2020 Corporate Participants: Raphael Gross -- Investor Relations Brendan Kennedy -- Chief Executive Officer Michael
Tilray Q2 loss widens despite revenue growth; results miss
https://www.youtube.com/watch?v=KqNZ-_X4F8k&t=2s Cannabis company Tilray, Inc. (NASDAQ: TLRY) Monday reported a wider net loss for the second quarter of 2020, despite a marked
Tilray’s (TLRY) loss widens in Q1 despite minimal impact from COVID-19
Tilray (NASDAQ: TLRY) reported mixed results yesterday for its first quarter of 2020. Despite revenue rising more than 100% in the quarter,
Tilray Inc (NASDAQ: TLRY) Q1 2020 Earnings Call Transcript
Tilray Inc (TLRY) Q1 2020 earnings call dated May. 11, 2020 Corporate Participants: Raphael Gross -- Investor Relations Brendan Kennedy -- Chief Executive Officer Michael Kruteck -- Chief
Tilray Inc (NASDAQ: TLRY) Q4 2019 Earnings Call Transcript
Tilray Inc (NASDAQ: TLRY) Q4 2019 Earnings Conference Call Final Transcript Corporate Participants: Brendan Kennedy -- Chairman, President and Chief Executive Officer Mark Castaneda -- Chief Financial
Tilray (TLRY) Q4 loss widens amid industry headwinds, despite sales growth; stock falls
Days after announcing an extensive restructuring program, which includes tough measures like workforce reduction, cannabis producer Tilray, Inc. (NASDAQ: TLRY) reported a
Tilray (TLRY) to benefit in Q4 from global expansions and strategic partnerships
Tilray (Nasdaq: TLRY) will issue its fourth quarter and full-year 2019 earnings results on Monday, March 2, 2020 after the market close.
Tilray (TLRY) stock retreats on layoff panic
Tilray Inc. (NASDAQ: TLRY) stock retreated and is trading near the record low of $15.01 on Friday as investors remained concerned about
Cannabis stocks: Major players see a pickup amid FDA warnings
The stocks of major cannabis companies appear to be picking up after seeing a drop following FDA warnings over the safety of
Tilray’s (TLRY) loss widens in Q3; revenue beats estimates
Tilray's (NASDAQ: TLRY) loss of $0.36 per share in the third quarter was wider than the year-ago loss of $0.20 per share.
What to look for when Tilray (TLRY) reports Q3 earnings results?
Tilray Inc. (NASDAQ: TLRY) is slated to report third quarter 2019 earnings results on Tuesday, November 12, after the market closes. Analysts
Tilray lingers near a yearly low as lack of clarity about pot industry continues
Tilray Inc. (NASDAQ: TLRY) stock is trading near the yearly low on Wednesday after falling over 64% in the year so far
Neptune Wellness posts wider losses in Q4, shares fall
Canadian producer of wellness products, Neptune Wellness Solutions (NASDAQ: NEPT), said its revenues fell 16% in the first quarter to $5.7 million,
Tilray stock heads downward on doubts of cannabis risks
Tilray (NASDAQ: TLRY) stock has fallen over 47% in the year so far. The stock has been on a downward trend since
Tilray Q1 loss widens, meets estimates
Tilray (TLRY) reported a wider loss in the first quarter of 2019 due to higher operating costs and expenses. The company is
Calendar: Earnings of Tilray, Aurora Cannabis, Cisco, Walmart, Nvidia on queue
Tilray, Aurora Cannabis, Cisco, Walmart, Nvidia, and more earnings are scheduled for the week between May 13 and 17. Check out what
Tilray earnings preview: Investors need more than just production expansion
Though the marijuana industry has been seeing overall tremendous growth, one prominent name has been pulling it down – Tilray (NASDAQ: TLRY).
Marijuana vs US: Will Aurora Cannabis survive in the banned market?
In the US, marijuana has been slowly turning to be legal in certain states but it still remained banned at the federal
Q4 earnings preview: New Age Beverages to benefit from CBD-infused beverages
New Age Beverages (NBEV) is set to report its Q4 and full-year 2018 results on Friday, March 29 before market opens. Analysts
Tilray posts wider-than-expected Q4 loss
Tilray (TLRY) reported a wider loss in the fourth quarter due to higher operating costs and expenses. For surviving the rising competition